Literature DB >> 17222924

Vasodilator effects of peptides derived from egg white proteins.

Marta Miguel1, Yolanda Alvarez, Rosina López-Fandiño, María J Alonso, Mercedes Salaices.   

Abstract

The aim of this work was to investigate the effect of several peptides, identified before and after simulated gastrointestinal digestion of an egg white hydrolysate, on the vascular function, in rat aorta. The sequences IVF, RADHPFL and YAEERYPIL (0.1 mM) induced vasodilatation in intact aortic rings, with the maximum percentage of dilation corresponding to RADHPFL (40.5+/-7.0%). Two of the end products of the gastrointestinal digestion, RADHP and YPI, also showed vasodilator activity with degrees of relaxation higher than 50%. However, all these peptides failed to induce relaxation in endothelium-denuded aortic rings. The relaxation induced by RADHP was concentration-dependent and it was partially blocked by the nitric oxide synthase inhibitor L-NAME (100 microM) and by the B(1) bradykinin receptor antagonist Des-HOE 140 (30 nM), thus showing that it was mediated by NO production through the activation of B(1) bradykinin receptors. These findings suggest that these peptides could reduce the vascular resistance and could be used as functional food ingredients in the prevention and treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222924     DOI: 10.1016/j.regpep.2006.11.029

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

1.  Vasoactive properties of keratin-derived compounds.

Authors:  Fiesky Nunez; Simon Trach; Luke Burnett; Rahul Handa; Mark Van Dyke; Michael Callahan; Thomas Smith
Journal:  Microcirculation       Date:  2011-11       Impact factor: 2.628

2.  The anti-atherosclerotic di-peptide, Trp-His, inhibits the phosphorylation of voltage-dependent L-type Ca(2+) channels in rat vascular smooth muscle cells.

Authors:  Yutaro Kobayashi; Toshihiko Fukuda; Mitsuru Tanaka; Toshiro Matsui
Journal:  FEBS Open Bio       Date:  2012-04-17       Impact factor: 2.693

3.  Regulation of blood pressure and glucose metabolism induced by L-tryptophan in stroke-prone spontaneously hypertensive rats.

Authors:  Hitoshi Shirakawa; Yuto Inagawa; Takuya Koseki; Michio Komai
Journal:  Nutr Metab (Lond)       Date:  2011-06-28       Impact factor: 4.169

4.  Hypotensive and vasorelaxant effects of sericin-derived oligopeptides in rats.

Authors:  Amnart Onsa-Ard; Dawan Shimbhu; Jiraporn Tocharus; Manote Sutheerawattananonda; Rungusa Pantan; Chainarong Tocharus
Journal:  ISRN Pharmacol       Date:  2013-11-07

Review 5.  Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension.

Authors:  Kaustav Majumder; Jianping Wu
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

6.  Biological and functional properties of proteolytic enzyme-modified egg protein by-products.

Authors:  Marta Pokora; Ewelina Eckert; Aleksandra Zambrowicz; Lukasz Bobak; Marek Szołtysik; Anna Dąbrowska; Józefa Chrzanowska; Antoni Polanowski; Tadeusz Trziszka
Journal:  Food Sci Nutr       Date:  2013-02-14       Impact factor: 2.863

7.  Pepsin Egg White Hydrolysate Improves Glucose Metabolism Complications Related to Metabolic Syndrome in Zucker Fatty Rats.

Authors:  Marta Garcés-Rimón; Cristina González; Gema Vera; José-A Uranga; Rosina López-Fandiño; Visitación López-Miranda; Marta Miguel
Journal:  Nutrients       Date:  2018-04-03       Impact factor: 5.717

8.  Enzymatic Hydrolysis of Egg White Protein Exerts a Hypotensive Effect in Spontaneously Hypertensive Rats.

Authors:  Da-Eon Lee; Tae-Hwan Jung; Yu-Na Jo; Sung-Seob Yun; Kyoung-Sik Han
Journal:  Food Sci Anim Resour       Date:  2019-12-31

9.  Bioactivity of Cooked Standard and Enriched Whole Eggs from White Leghorn and Rhode Island Red in Exhibiting In-Vitro Antioxidant and ACE-Inhibitory Effects.

Authors:  Emerson Nolasco; Mike Naldrett; Sophie Alvarez; Philip E Johnson; Kaustav Majumder
Journal:  Nutrients       Date:  2021-11-25       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.